[go: up one dir, main page]

BR9608938A - Derivados dse fenóxi piperazina para o tratamento de distúrbios do sistema de dopamina - Google Patents

Derivados dse fenóxi piperazina para o tratamento de distúrbios do sistema de dopamina

Info

Publication number
BR9608938A
BR9608938A BR9608938A BR9608938A BR9608938A BR 9608938 A BR9608938 A BR 9608938A BR 9608938 A BR9608938 A BR 9608938A BR 9608938 A BR9608938 A BR 9608938A BR 9608938 A BR9608938 A BR 9608938A
Authority
BR
Brazil
Prior art keywords
piperazine
treatment
system disorders
dopamine system
phenoxy derivatives
Prior art date
Application number
BR9608938A
Other languages
English (en)
Inventor
Thierry Godel
Deborah Hartman
Claus Riemer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9608938A publication Critical patent/BR9608938A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
BR9608938A 1995-06-09 1996-06-04 Derivados dse fenóxi piperazina para o tratamento de distúrbios do sistema de dopamina BR9608938A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH170395 1995-06-09
PCT/EP1996/002428 WO1996041630A1 (en) 1995-06-09 1996-06-04 Phenoxy piperazine derivatives for treating disorders of the dopamine system

Publications (1)

Publication Number Publication Date
BR9608938A true BR9608938A (pt) 1999-06-29

Family

ID=4216630

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608938A BR9608938A (pt) 1995-06-09 1996-06-04 Derivados dse fenóxi piperazina para o tratamento de distúrbios do sistema de dopamina

Country Status (9)

Country Link
US (1) US5614526A (pt)
EP (1) EP0833639A1 (pt)
JP (1) JP3076065B2 (pt)
CN (1) CN1090480C (pt)
AU (1) AU6222096A (pt)
BR (1) BR9608938A (pt)
CA (1) CA2222225A1 (pt)
TR (1) TR199701580T1 (pt)
WO (1) WO1996041630A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172919C (zh) 2002-06-03 2004-10-27 上海医药工业研究院 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
US7071204B2 (en) * 2003-06-30 2006-07-04 Research Triangle Institute Camptothecin analogs having an E-ring ketone
WO2009156458A1 (en) * 2008-06-27 2009-12-30 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9056859B2 (en) 2010-10-29 2015-06-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
RU2014110401A (ru) 2011-08-19 2015-09-27 Мерк Шарп И Доум Корп. Ингибиторы внешнего медуллярного калиевого канала почек
US9527830B2 (en) 2011-09-16 2016-12-27 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771005B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062900A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773206B1 (en) 2011-10-31 2018-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9139585B2 (en) 2011-10-31 2015-09-22 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
US9493474B2 (en) 2011-10-31 2016-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2790511B1 (en) 2011-12-16 2016-09-14 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9573961B2 (en) 2012-12-19 2017-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014126944A2 (en) 2013-02-18 2014-08-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9765074B2 (en) 2013-03-15 2017-09-19 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP3027625B1 (en) 2013-07-31 2018-05-30 Merck Sharp & Dohme Corp. Spiro-fused derivatives of piperidine useful for the treatment of inter alia hypertension and acute or chronic heart failure
WO2015065866A1 (en) 2013-10-31 2015-05-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof

Also Published As

Publication number Publication date
WO1996041630A1 (en) 1996-12-27
CN1187128A (zh) 1998-07-08
AU6222096A (en) 1997-01-09
US5614526A (en) 1997-03-25
CN1090480C (zh) 2002-09-11
TR199701580T1 (xx) 1998-03-21
MX9709396A (es) 1998-07-31
EP0833639A1 (en) 1998-04-08
JP3076065B2 (ja) 2000-08-14
JPH10507777A (ja) 1998-07-28
CA2222225A1 (en) 1996-12-27

Similar Documents

Publication Publication Date Title
BR9608938A (pt) Derivados dse fenóxi piperazina para o tratamento de distúrbios do sistema de dopamina
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
BR9503531A (pt) Sistema de suspensão para transdutores
PT1144395E (pt) Derivados de 2-aminobenzoxazinona para o tratamento da obesidade
DE69840290D1 (de) Einstellbare rechnergestützte tomographie anlage
PT1143977E (pt) Derivados de 2-oxibenzoxazinona para o tratamento da obesidade
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
PT912194E (pt) Formula de vacina polinucleotidica particularmente contra doenca respiratoria dos bovinos
BR9501525A (pt) Sistema de montagem para uma barra de ferramentas
PT1339406E (pt) Derivados de piperazina, sua preparacao e sua utilizacao para o tratamento de disturbios dos sistema nervoso central (snc)
NO972937D0 (no) Farmasöytiske piperazinforbindelser
BR9604828A (pt) Sistema de tratamento efluente de meios aquosos
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
BR9604829A (pt) Sistema de tratamento de meios aquosos para filtros auto- limpantes
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
PT1089965E (pt) Derivados de ureia para tratamento da dor
PT1051172E (pt) Metodo para tratamento da dpco
FR2728268B1 (fr) Procede de preparation de gamma-cyclodextrine
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
FR2750987B1 (fr) Procede de preparation de methionine
BR9602677A (pt) Sistema de medição para canícula retificada

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]